Yettwaleqqem
WHO updated recommendations on HIV clinical management: recommendations for a public health approach
World Health Organization
Tuḍḍiwin n tɣawsiwin 2025TAFFA N TMUSNIWIN TUSNANIN
Ilugan n usḍibbi
Af-d ilugan unṣiben, arraten n umtawa d yileqman i d-ssufɣen yimusnawen d tedbirtin n ṣṣeḥḥa.
Iɣbula unṣiben, yettwamanenTuddsiwin tusnawin d tedbirtin n ṣṣeḥḥa
Isallen yettwaleqqmenAsenqed ussnan ameɣlal
Anekcum s war azal i yimseɣtayenI ɣur n temɣiwent n yimdanen n tẓṛi
ASNAS ASEM
Iwellihen klinikiyen, anda tebɣuḍ
Snirem iwellihen imuddisen unṣiben d yilugan klinikiyen deg usnas ASEM.
Sader asnas ASEMTisuffaɣ d ileqman ixataren
Wali isuffeɣen ineggura
Yettwaleqqem
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
European Society of Cardiology
Tasleḍt n wul 2025
Asuffeɣ unṣib
Retinopathy of prematurity: Strategies to optimize screening and management
Canadian Paediatric Society
Taseḍṛit n warrac 2026Akk yilugan (525 igmuḍ)
Imsizzel
2021 ESC Guidelines on Cardiovascular Disease Prevention in Clinical Practice
European Society of Cardiology
Official European Society of Cardiology document (2021) on “2021 ESC Guidelines on Cardiovascular Disease Prevention in Clinical Practice”. 2021 ESC Guidelines on Cardiovascular Di...
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
European Society of Cardiology
Official European Society of Cardiology document (2021) on “2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy”. 2021 ESC Guidelines on cardiac pacing and...
Selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors in pregnancy: Infant and childhood outcomes
Canadian Paediatric Society
Official Canadian Paediatric Society document (2021) on “Selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors in pregnancy: Infant and childhood...
Adrenal suppression from exogenous glucocorticoids: Recognizing risk factors and preventing morbidity
Canadian Paediatric Society
Official Canadian Paediatric Society document (2021) on “Adrenal suppression from exogenous glucocorticoids: Recognizing risk factors and preventing morbidity”. Adrenal suppression...
Early Childhood Caries in Indigenous Communities
Canadian Paediatric Society
Official Canadian Paediatric Society document (2021) on “Early Childhood Caries in Indigenous Communities”. The oral health of Indigenous children of Canada (First Nations, Inuit,...
Non-IgE-mediated food allergy: Evaluation and management
Canadian Paediatric Society
Official Canadian Paediatric Society document (2021) on “Non-IgE-mediated food allergy: Evaluation and management”. The most common types of non-IgE-mediated food allergy are food...
Protecting children and adolescents against the risks of vaping
Canadian Paediatric Society
Official Canadian Paediatric Society document (2021) on “Protecting children and adolescents against the risks of vaping”. Youth vaping presents significant risks for the health an...
The use of oral opioids to control children’s pain in the post-codeine era
Canadian Paediatric Society
Official Canadian Paediatric Society document (2021) on “The use of oral opioids to control children’s pain in the post-codeine era”. Pain is a common problem for children, and pai...
Guidelines for surfactant replacement therapy in neonates
Canadian Paediatric Society
Official Canadian Paediatric Society document (2021) on “Guidelines for surfactant replacement therapy in neonates”. Abstract Surfactant replacement therapy (SRT) plays a pivotal r...
Emergency management of the paediatric patient with convulsive status epilepticus
Canadian Paediatric Society
Official Canadian Paediatric Society document (2021) on “Emergency management of the paediatric patient with convulsive status epilepticus”. This guideline addresses the emergency...